These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

30 related articles for article (PubMed ID: 28218319)

  • 1. Securing the Payload, Finding the Cell, and Avoiding the Endosome: Peptide-Targeted, Fusogenic Porous Silicon Nanoparticles for Delivery of siRNA.
    Kim B; Sun S; Varner JA; Howell SB; Ruoslahti E; Sailor MJ
    Adv Mater; 2019 Aug; 31(35):e1902952. PubMed ID: 31267590
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Multifunctional Envelope-Type siRNA Delivery Nanoparticle Platform for Prostate Cancer Therapy.
    Xu X; Wu J; Liu Y; Saw PE; Tao W; Yu M; Zope H; Si M; Victorious A; Rasmussen J; Ayyash D; Farokhzad OC; Shi J
    ACS Nano; 2017 Mar; 11(3):2618-2627. PubMed ID: 28240870
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lipid and Peptide-Oligonucleotide Conjugates for Therapeutic Purposes: From Simple Hybrids to Complex Multifunctional Assemblies.
    Fàbrega C; Aviñó A; Navarro N; Jorge AF; Grijalvo S; Eritja R
    Pharmaceutics; 2023 Jan; 15(2):. PubMed ID: 36839642
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Peptide-based delivery of therapeutics in cancer treatment.
    Samec T; Boulos J; Gilmore S; Hazelton A; Alexander-Bryant A
    Mater Today Bio; 2022 Mar; 14():100248. PubMed ID: 35434595
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Understanding and targeting the disease-related RNA binding protein human antigen R (HuR).
    Schultz CW; Preet R; Dhir T; Dixon DA; Brody JR
    Wiley Interdiscip Rev RNA; 2020 May; 11(3):e1581. PubMed ID: 31970930
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Current Aspects of siRNA Bioconjugate for In Vitro and In Vivo Delivery.
    Tai W
    Molecules; 2019 Jun; 24(12):. PubMed ID: 31200490
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthetic SiRNA Delivery: Progress and Prospects.
    Roberts TC; Ezzat K; El Andaloussi S; Weinberg MS
    Methods Mol Biol; 2016; 1364():291-310. PubMed ID: 26472459
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nanoparticles for targeted delivery of therapeutics and small interfering RNAs in hepatocellular carcinoma.
    Varshosaz J; Farzan M
    World J Gastroenterol; 2015 Nov; 21(42):12022-41. PubMed ID: 26576089
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Strategies for in vivo delivery of siRNAs: recent progress.
    Higuchi Y; Kawakami S; Hashida M
    BioDrugs; 2010 Jun; 24(3):195-205. PubMed ID: 20462284
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficient siRNA-peptide conjugation for specific targeted delivery into tumor cells.
    Gandioso A; Massaguer A; Villegas N; Salvans C; Sánchez D; Brun-Heath I; Marchán V; Orozco M; Terrazas M
    Chem Commun (Camb); 2017 Mar; 53(19):2870-2873. PubMed ID: 28218319
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of multimeric siRNA conjugates for efficient protamine-based delivery into breast cancer cells.
    Yoo H; Mok H
    Arch Pharm Res; 2015 Jan; 38(1):129-36. PubMed ID: 24687259
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Multifunctional peptide-lipid nanocomplexes for efficient targeted delivery of DNA and siRNA into breast cancer cells.
    Wan Y; Dai W; Nevagi RJ; Toth I; Moyle PM
    Acta Biomater; 2017 Sep; 59():257-268. PubMed ID: 28655658
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficient siRNA targeted delivery into cancer cells by gastrin-releasing peptides.
    Sioud M; Mobergslien A
    Bioconjug Chem; 2012 May; 23(5):1040-9. PubMed ID: 22443209
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CXCR4-targeted modular peptide carriers for efficient anti-VEGF siRNA delivery.
    Egorova A; Shubina A; Sokolov D; Selkov S; Baranov V; Kiselev A
    Int J Pharm; 2016 Dec; 515(1-2):431-440. PubMed ID: 27789364
    [TBL] [Abstract][Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.